Swizzard welcomes Philipp Heider as Medical & Market Access Associate Director

Swizzard Pharma AG, a solution provider that supports biotech and pharma companies in successfully entering and thriving in the Swiss market, welcomes Philipp Heider as Medical & Market Access Associate Director.

Philipp holds a Master of Science in Biotechnology from the Management Center Innsbruck and recently completed a CAS in Digital Life Sciences at Zurich University of Applied Sciences (ZHAW). His academic profile is complemented by certifications in Good Clinical Practice, Scrum Product Ownership and process analysis.

With more than five years of experience across medical affairs, market access and scientific research, Philipp combines a medical background with a passion for digital innovation. He supports Swizzard’s clients through strategic planning and execution of medical and market access projects, including MSL activities, KOL mapping, pricing dossiers and reimbursement negotiations.

Prior to joining Swizzard, Philipp held the role of Medical Science Liaison Manager Oncology at Daiichi Sankyo (Schweiz) AG, where he built and maintained partnerships with healthcare professionals, patient groups and research centers. His responsibilities included dissemination of clinical trial data, insight generation, medical information and support of multiple oncology trials in Switzerland. Philipp also contributed to the “AI for Medical Affairs” work stream, an initiative to develop new digital solutions for medical information delivery.

Earlier in his career, Philipp also worked at Sartorius Stedim Switzerland AG as a Key Account Manager, providing technical process consulting in bioprocessing and process analytics, and at Amgen GmbH in Medical Scientific Communications, where he supported the development of scientific materials for oncology therapies and diagnostics.

“I’m inspired to deliver solutions that make a difference to Swizzard’s clients – and ultimately patients – in an increasingly data-driven, AI-enabled healthcare landscape,” says Philipp.

“Philipp brings a rare combination of medical expertise, industry experience and data analytics capabilities says Michael Zürcher,” CEO of Swizzard. “His digital mindset will help take Swizzard and our clients into the future.”

---

About Swizzard

Swizzard Pharma AG supports biotech and pharma companies in successfully entering and thriving in the Swiss market. Committed to bringing innovation to Switzerland, Swizzard helps clients maximize the value of their medical breakthroughs through expert market entry, preparation, commercialization and access strategies. With deep industry expertise, hands-on experience and an extensive network, Swizzard delivers fast, efficient, and tailored solutions. The company is led by CEO Michael Zürcher, a seasoned life sciences executive with a strong track record in the industry.

Contact us